Evidence map›Paper›PMID 36852982›Full record

ArticleJournal of bacteriology2023

Genetic, Functional, and Immunogenic Analyses of the

Lisbeth M Næss, Ingunn S Maugesten, Dominique A Caugant, Afework Kassu, Abraham Aseffa, Bente Børud

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bacteriology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Sweet complexity:Frontiers in cellular and infection microbiology · 2024
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Lisbeth M Næss *Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Ingunn S Maugesten *Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Dominique A CaugantDivision of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Afework KassuArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Abraham AseffaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Bente BørudDivision of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Norwegian Institute of Public Health · NOArmauer Hansen Research Institute · ETUniversity of Oslo · NO

Funding

Renee og Bredo Grimsgaard's FoundationResearch Council of Norway 220829
6 · The paper itself

Abstract

Neisseria meningitidis exhibits a general

Indexed as

Meningococcal InfectionsMeningococcal VaccinesNeisseria meningitidisBacterial ProteinsGlycosylationHumansPolysaccharidesSerogroupBacterial ProteinsMeningococcal VaccinesPolysaccharidesglycan diversityimmune responsemicroheterogeneityNeisseria meningitidisO-linked protein glycosylationserum bactericidal activity

Identifiers

PMID36852982
PMCPMC10029716
OpenAlexW4322617994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.